Discover the difference with PlexPrime® SARS-CoV-2 Genotyping*
Research reagents to support investigation of COVID-19 variants of concern
PlexPrime® products – powered by PlexZyme® & PlexPrime® technology – offer superior multiplex mutation detection. Our patented priming approach generates unique amplicons for target specific amplification and detection, improving specificity even across clustered mutations. Multiplexing key mutations for single-well detection further streamlines your testing process.
Choose PlexPrime® technology and place your lab at the forefront of SARS-CoV-2 mutation detection.
| Product Availability | |||
|---|---|---|---|
| PlexPrime® SARS-CoV-2 Alpha/Beta/Gamma+*† | Access Datasheet | ||
| PlexPrime® SARS-CoV-2 P681R Delta* | Access Datasheet | ||
| PlexPrime® SARS-CoV-2 L452Q Lambda* | Access Datasheet | ||
*PlexPrime® products are research use only, not for use in diagnostic procedures
†The PlexPrime® SARS-CoV-2 Alpha/Beta/Gamma+ components also identify Omicron variants, including BA.2
Clear the path towards enhanced laboratory efficiency and support public health measures in response to the COVID-19 pandemic.
PlexPrime® SARS-CoV-2 Genotyping reagents are designed to detect mutations associated with variants of concern (VOC). VOCs are linked to increased transmissibility or severity of disease. PlexPrime® mutation detection products generate actionable, reportable data in only a few hours, enabling proactive management of public health crises.
Increase laboratory productivity
Improve throughput and minimise hands-on time by reducing the number of reflex reactions required in your variant investigations.
PlexPrime® SARS-CoV-2 Genotyping allows for detection of multiple mutations linked to VOC in a single well using only a small amount of sample extract.
- Streamline testing – Realise efficiency through multiplex solutions, process more samples per plate, and easily respond to test number fluctuations or periodic surges in COVID-19 cases
- Preserve valuable extract – Minimize the number of reactions required to detect key mutations, plus each multiplexed well requires only 20µl of sample extract.
- Have confidence in your results with superior technology – Our PlexPrime® technology enables simultaneous multiplex mutation detection in a single well without compromising on specificity or sensitivity.
Focus your sequencing efforts
Reduce the cost, time, and complexity of sequence-based variant analysis. Sequencing is key to support ongoing variant monitoring, but is an unsustainable long-term solution for large amounts of SARS-CoV-2- positive samples.
Use PlexPrime® SARS-CoV-2 Genotyping products to identify key mutations and clear a path for sequencing the correct positive samples.
- Resource management – Identify the positives of interest and reduce the burden on your highly skilled staff
- Value – Focus data collection efforts using your existing qPCR platform – smarter sequencing reduces overall laboratory costs.
We routinely monitor and assess emerging variants of concern and high consequence, to continually develop appropriate detection tools for key mutations. The versatility of our PlexPrime® technology supports rapid evolution of our SARS-CoV-2 Genotyping solutions as additional variants of concern are designated.
Security of Supply
Supply chains have been increasingly strained throughout the COVID-19 pandemic. SpeeDx PlexPCR® technology de-couples the detection probe from the target sequence – resulting in universal probes suited for multiple assays and applications.
- Streamlined manufacturing – We manufacture in bulk to support high volume ordering and demand fluctuations.
- Unique technology – Our universal-probe approach ensures no interruptions to your daily testing and secures supply of essential reagents for your laboratory.
